Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

39 results about "Guanidine thiocyanate" patented technology

Method for extracting animal muscular tissue DNA efficiently and safely

PendingCN105985948AIncreased possibility of cross-contaminationNo harmDNA preparationDecompositionAdditive ingredient
The invention discloses a method for extracting animal muscular tissue DNA easily, conveniently, safely and fast. The method comprises the steps that after pork, mutton, beef and chicken are washed with clean water, connective tissue and fat in animal tissue are removed; the animal tissue is shorn into small blocks of 200 mg, and the small blocks are placed in liquid nitrogen and fast ground till powder is obtained; 100 mg of the powder is taken to be placed in a 2-mL centrifuge tube, and the DNA is extracted through SDS splitting decomposition, isopropanol precipitating and adsorption column purification and can be directly used for PCR amplification. The DNA extracting method is adopted, and the whole process of DNA extraction of a sample can be completed within 2 hours. The quality standard of the extracted DNA meets the requirement of subsequent PCR amplification, meanwhile, the harm of various organic reagents to experiment staff in the extraction process of a traditional SDS method or guanidine thiocyanate method is avoided, and time is greatly shortened; the method is more suitable for achieving the aim of efficiently and fast extracting sample DNA in the animal source ingredient identification process, and has the advantages of being efficient, fast, low in cost, easy and convenient to operate, free of toxicity, safe and the like.
Owner:TIANJIN INSTITUE OF QUALITY STANDARD & TESTING OF AGRICULTUAL PRODS

Fecal microorganism preserving fluid and preparation method thereof

InactiveCN110628631AEasy to useEnhance the storage effect at room temperatureMicroorganism preservationMicroorganism preservationStabilizing Agents
The invention discloses a fecal microorganism preserving fluid. The preserving fluid comprises a protein inhibitor, a stabilizer with a chelating agent and a preservative effect, a biological buffer solution, a metal chelating agent, sodium chloride and water, the final concentration of the protein inhibitor is 0.1-2 mol/L, the final concentration of the metal chelating agent is 1-100 mmol/L, thefinal concentration of the sodium chloride is 0.1-1 mol/L, the final concentration of the biological buffer solution is 1-100 mmol/L, and the final concentration of the stabilizer is 0.1%/L-10%/L. Theinvention further discloses a preparation method of the fecal microorganism preserving fluid, which comprises the follows several steps: step 1, adding 1/2 of sterile water by volume to a container;step 2, sequentially adding the sodium chloride, a Tris-CI buffer solution, ethylenediamine tetraacetic acid, the stabilizer and guanidine thiocyanate to the container; step 3, adding deionized waterto complete volume metering; and step 4, adjusting PH to 7.5, and performing sterilization and room-temperature cooling to obtain the preserving fluid. The preserving fluid has the advantages that thenormal-temperature preserving effect on samples is good, the preserving fluid is convenient to use, the whole preparation method is simple and the like.
Owner:中诺(杭州)基因科技有限责任公司

Reagent kit for influenza a H3N2 type fluorescent PCR diagnosis and use method thereof

The invention provides a reagent kit for influenza a H3N2 type fluorescent PCR diagnosis. The reagent kit comprises RNA extraction solutions and a PCR reaction solution. The RNA extraction solutions comprise the RNA extraction solution I, the RNA extraction solution II, the RNA extraction solution III and the RNA extraction solution IV. The RNA extraction solution I is prepared from lauryl sodium sulfate, triton, guanidine thiocyanate and magnetic beads. The RNA extraction solution II is prepared from 4-(2-hydroxyerhyl) piperazine-1-erhaesulfonic acid and sodium chloride. The RNA extraction solution III is prepared from triton and sodium chloride. The RNA extraction solution IV is prepared from mineral oil. The PCR reaction solution comprises an upstream primer, a downstream primer and a probe, wherein the upstream primer and the downstream primer are used for target polynucleotide amplification, and the probe is used for target polynucleotide detection. The reagent kit is an influenza a H3N2 type fluorescent PCR diagnosis product excellent in RNA extraction rate and detection sensitivity. Typing detection can be carried out on influenza a viruses in throat swabs and various samples to judge whether patients are infected with the influenza a H3N2 type or not and assist doctors in making better diagnosis and more precise treatment.
Owner:SANSURE BIOTECH INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products